Trademarkia Logo

Canada

C$
Trademark Search in Canada
EXPANDING LIFE

View On IC.GC.CA

EXPANDING LIFE
REGISTERED

on 5 Aug 2022

Last Applicant/ Owned by

Nanobiotix, Société anonyme

60 rue de Wattignies75012 Paris

FR

Serial Number

1911629 filed on 26th Jul 2018

Registration Number

TMA1136930 registered on 5th Aug 2022

Registration expiry Date

5th Aug 2032

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

EXPANDING LIFE

Trademark usage description

pharmaceuticals and medical preparations for use in oncology, none of which will be sold in brick and mortar retail stores; pharmaceuticals and medica Read More

Classification Information

Class [005]
Pharmaceuticals and medical preparations for use in oncology, none of which will be sold in brick and mortar retail stores; pharmaceuticals and medical preparations for the treatment of and neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; fungicides, herbicides, none of which will be sold in brick and mortar retail stores; medicines for human purposes, comprising metal- and metal oxide-containing nanoscale particles, for use in oncology, none of which will be sold in brick and mortar retail stores; medicines for human purposes, comprising metal- and metal oxide-containing nanoscale particles, for the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; antibiotics, none of which will be sold in brick and mortar retail stores; antiseptics, none of which will be sold in brick and mortar retail stores; chemical-pharmaceutical preparations comprising metal- and metal oxide- containing nanoscale particles namely drug formulations in the form of intravenous and injectable formulations, and gels for use in the field of radio- oncology, none of which will be sold in brick and mortar retail stores; chemical pharmaceutical preparations comprising metal- and metal oxidecontaining nanoscale particles namely drug formulations in the form of IV and injectable formulations, and gels for use in the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; radiological contrast substances for medical use, none of which will be sold in brick and mortar retail stores; chemical preparations , comprising metal- and metal oxide-containing nanoscale particles, for medical and pharmaceutical use, for use in radio-oncology and in the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; diagnostic preparations comprising metal- and metal oxide-containing nanoscale particles, for medical use, in the field of radio-oncology, none of which will be sold in brick and mortar retail stores; diagnostic preparations comprising metal- and metal oxide-containing nanoscale particles, for medical use, in the field of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; drugs for medical use, namely anti tumour drugs, none of which will be sold in brick and mortar retail stores; drugs for medical use, namely pharmaceutical preparations, used in combination with radiotherapy, for the treatment of cancer, none of which will be sold in brick and mortar retail stores; drugs for medical use, namely pharmaceutical preparations, used in combination with radiotherapy, for the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; restorative medicines comprising metal- and metal oxide- containing nanoscale particles for use in radiooncology, none of which will be sold in brick and mortar retail stores; restorative medicines comprising metaland metal oxide-containing nanoscale particles for the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores; preparations for medical use particularly for the diagnosis and treatment of tumors, none of which will be sold in brick and mortar retail stores; preparations namely pharmaceutical preparations for medical use in the field of radiooncology and for the treatment of neurodegenerative diseases namely Alzheimer's disease, Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and dementia, none of which will be sold in brick and mortar retail stores

Classification kind code

11

Class [009]
Computer programs and software regarding health, namely computer programs and software for medical imaging

Classification kind code

11

Class [010]
Instruments for physics, chemistry, electrotechnical, namely instruments for drug delivery in the fields of radio-oncology and neurodegenerative diseases, namely, intra-tumoral and intracranial injection and monitoring devices; surgical and medical apparatus for generating ionizing radiation; surgical and medical apparatus for drug delivery in the fields of radio-oncology and for the treatment of neurodegenerative diseases; radiotherapy apparatus in the field of radio-oncology optimizing the use of injectable radioenhancers; diagnostic apparatus for medical use, namely medical X-ray apparatus; radiology screens for medical use; surgical and medical apparatus and instruments for drug delivery in the fields of radio-oncology and for the treatment of neurodegenerative diseases, namely, intra-tumoral and intracranial injection and monitoring devices

Classification kind code

11

Class [038]
Radio broadcasting via wired or wireless networks namely, Internet radio broadcasting; television broadcasting; broadcasting of films and television and radio programmes via the Internet; provision of online forums for doctors, patients and any parties interested in radio-oncology; provision of online forums for doctors, patients and any parties interested in neurodegenerative diseases; providing access to electronic databases containing information related to medical science, in the field of oncology and neurodegenerative diseases

Classification kind code

11

Class [041]
Publication of books; arranging and conducting of colloquiums, namely organisation of colloquiums in the field of medical science; arranging and conducting of conferences, namely organisation of conferences and symposia in the field of medical science; arranging and conducting of congresses, namely organisation of congresses in the field of medical science; organization of exhibitions for educational purposes in the field of medical science

Classification kind code

11

Class [042]
Scientific and technological research services in the fields of oncology and neurodegenerative diseases; biological research in the field of oncology and neurodegenerative diseases; bacteriological research; chemical analysis; chemical research; chemistry services, namely, research in the field of nanochemistry; technical research in the field of oncology and neurodegenerative diseases; research in radiobiology; research in nanoscience and nanotechnology, particularly applied to medicine; scientific research in the field of oncology and neurodegenerative diseases; scientific and technological research and design services in the field of nanomedicine namely nanotechnology applied to medicine

Classification kind code

11

Class [044]
Health care services for treating cancer and neurodegenerative diseases in the field of nanomedicine; medical care services for treating cancer and neurodegenerative diseases in the field of nanomedicine; hospital services; consulting in the field of health care services for treating cancer; consulting in the field of health, namely in the field of neuroscience; ambulant medical care; medical care services relating to patient treatment

Classification kind code

11

Mark Details

Serial Number

1911629

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 71
on 20th Jul 2022		Opposition Removed
Submitted for opposition 110
on 21st Jun 2021		Proposed Opposition
Submitted for opposition 42
on 5th May 2021		Advertised
Submitted for opposition 26
on 22nd Mar 2021		Approved
Submitted for opposition 27
on 22nd Mar 2021		Approval Notice Sent
Submitted for opposition 22
on 20th May 2020		Search Recorded
Submitted for opposition 20
on 20th May 2020		Examiner's First Report
Submitted for opposition 31
on 30th Jul 2018		Formalized
Submitted for opposition 30
on 26th Jul 2018		Filed
Submitted for opposition 1
on 26th Jul 2018		Created